other:Article Title: Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase
Article Snippet: Primary antibodies used in this study include rabbit anti-CCRK (Abcam, Cat#ab227077; 1:1000), mouse anti-active β-catenin (Millipore, Cat#05-665; 1:2000), rabbit anti-β-catenin (Cell signaling, Cat#9562; 1:1000), rabbit anti-CCND1 (Invitrogen, Cat#PA5-12255; 1:1000), mouse anti-EGFR (BD laboratories, Cat#ABIN126775; 1:3000), mouse anti-PCNA (Abcam, Cat#ab201673; 1:2000), rabbit anti-caspase3 (Abcam, Cat#ab115183; 1:1000), rabbit anti-active caspase3 (Abcam, Cat#ab49822; 1:1000), rabbit anti-PARP (Abcam, Cat#ab227244; 1:2000), rabbit anti-cleaved PARP (Abcam, Cat#ab4830; 1:1000), rabbit anti-CDC25A (cell signaling, Cat#ab3652; 1:1000), rabbit anti-CDK6 (Abcam, Cat#ab151247; 1:1000), rabbit anti-CDKN1B (Abcam, Cat#ab215434; 1:1000) and mouse anti-β-actin (Sigma, Cat#A1978; 1:15000).
Article Title: Orientia tsutsugamushi modulates p53, the cell cycle, and genotoxicity to maintain its intracellular niche.
Article Snippet: Primary antibodies used were: mouse anti-p53 (Santa Cruz [sc-98]; 1:200), rabbit anti-p21 (Cell Signaling [#2947]; 1:1000), mouse anti-HDM2 (Invitrogen [#33-7100]; 1:500), mouse anti-Cyclin E (Santa Cruz, Dallas, TX [sc-377100]; 1:500), mouse anti-Cyclin A (Santa Cruz [sc-271682]; 1:250), mouse anti-Cyclin D3 (Cell Signaling, Danvers, MA [#2936]; 1:1000), rabbit anti-Cyclin D1 (Cell Signaling [#55506]; 1:1000), rabbit anti-Cyclin B1 (Cell Signaling [#4138]; 1:1000), rabbit anti-TCF11/NRF1 (Cell Signaling [#8052]; 1:1000), rabbit anti-GFP (Invitrogen [A11122]; 1:1000), rabbit antiGMNN (Cell Signaling [#52508]; 1:1000), rabbit anti-cdc25a (Cell Signaling [#3652]; 1:1000), rabbit anti-phosphorylated-Histone H2A.X (ƔH2AX) (Cell Signaling [#2577]; 1:1,1000), rabbit anti-Caspase 7 (Cell Signaling [#9492]; 1:1000), rabbit anti-Caspase 3 (Cell Signaling [#9662]; 1:1000), rabbit anti-PARP1 (Invitrogen [MA5-15031]; 1:1000), rabbit anti-PKR (Cell signaling [#3072; 1:1000), rabbit anti-p-PKR (T446) (Abcam [ab32036]; 1:1000), rabbit anti-O. tsutsugamushi TSA56123 (1:1000), mouse anti-GAPDH (Santa Cruz [sc-365062]; 1:750).
Article Title: Orientia tsutsugamushi modulates p53, the cell cycle, and genotoxicity to maintain its intracellular niche
Article Snippet: Primary antibodies used were: mouse anti-p53 (Santa Cruz [sc-98]; 1:200), rabbit anti-p21 (Cell Signaling [#2947]; 1:1000), mouse anti-HDM2 (Invitrogen [#33-7100]; 1:500), mouse anti-Cyclin E (Santa Cruz, Dallas, TX [sc-377100]; 1:500), mouse anti-Cyclin A (Santa Cruz [sc-271682]; 1:250), mouse anti-Cyclin D3 (Cell Signaling, Danvers, MA [#2936]; 1:1000), rabbit anti-Cyclin D1 (Cell Signaling [#55506]; 1:1000), rabbit anti-Cyclin B1 (Cell Signaling [#4138]; 1:1000), rabbit anti-TCF11/NRF1 (Cell Signaling [#8052]; 1:1000), rabbit anti-GFP (Invitrogen [A11122]; 1:1000), rabbit anti-GMNN (Cell Signaling [#52508]; 1:1000), rabbit anti-cdc25a (Cell Signaling [#3652]; 1:1000), rabbit anti-phosphorylated-Histone H2A.X (ƔH2AX) (Cell Signaling [#2577]; 1:1,1000), rabbit anti-Caspase 7 (Cell Signaling [#9492]; 1:1000), rabbit anti-Caspase 3 (Cell Signaling [#9662]; 1:1000), rabbit anti-PARP1 (Invitrogen [MA5-15031]; 1:1000), rabbit anti-PKR (Cell signaling [#3072; 1:1000), rabbit anti-p-PKR (T446) (Abcam [ab32036]; 1:1000), rabbit anti- O. tsutsugamushi TSA56 (1:1000), mouse anti-GAPDH (Santa Cruz [sc-365062]; 1:750).
Article Title: Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.
Article Snippet: Intrahepatic cholangiocarcinoma (ICC) has been reported to be the second most common primary hepatic carcinoma worldwide, and very limited therapies are currently available.. Serine threonine tyrosine kinase (STYK1), a member of the receptor tyrosine kinase family, exhibits tumorigenicity in many types of cancers and is a potential therapeutic target for ICC.. In this study, STYK1 was knocked down in the ICC cell lines HCCC-9810 and RBE via a lentivirus-mediated system using short hairpin RNA (shRNA).
Article Title: Obligate intracellular Orientia tsutsugamushi impedes TP53 expression to inhibit DNA damage-induced apoptosis
Article Snippet: Primary antibodies used were: mouse anti-p53 (Santa Cruz [sc-98]; 1:200), rabbit anti-p21 (Cell Signaling [#2947]; 1:1,000), mouse anti-HDM2 (Invitrogen [#33-7100]; 1:500), mouse anti-Cyclin E (Santa Cruz, Dallas, TX [sc-377100]; 1:500), mouse anti-Cyclin A (Santa Cruz [sc-271682]; 1:250), rabbit anti-Cyclin D3 (Cell Signaling, Danvers, MA [#2936]; 1:1,000), rabbit anti-Cyclin D1 (Cell Signaling [#55506]; 1:1,000), rabbit anti-Cyclin B1 (Cell Signaling [#4138]; 1:1,000), rabbit anti-GFP (Invitrogen [A11122]; 1:1000), rabbit anti-GMNN (Cell Signaling [#52508]; 1:1,000), rabbit anti-cdc25a (Cell Signaling [#3652]; 1:1,000), rabbit anti-Caspase 7 (Cell Signaling [#9492]; 1:1,000), rabbit anti-Caspase 3 (Cell Signaling [#9662]; 1:1,000), rabbit anti-PARP1 (Invitrogen [MA5-15031]; 1:1,000), rabbit anti-PKR (Cell signaling [#3072; 1:1,000), rabbit anti-p-PKR (T446) (Abcam [ab32036]; 1:1,000), rabbit anti- O. tsutsugamushi TSA56 (1:1,000), mouse anti-GAPDH (Santa Cruz [sc-365062]; 1:750).
Western Blot:Article Title: Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1
Article Snippet: Specific proteins were detected with enhanced chemiluminescence solution (P90720; Millipore) in an ImageQuant LAS-4000 digital imaging system (GE Healthcare). .. The primary antibodies used for western blotting were as follows: mouse anti-FOXM1 (sc-376471; 1:250 dilution; Santa Cruz Biotechnology), mouse anti-E2F1 (sc-193; 1:1000 dilution; Santa Cruz Biotechnology), rabbit anti-ATM (2873 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-ATM (phospho-Ser1981; 4526 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-MYPT1 (2634 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-MYPT1 (phospho-Thr835; 4563 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-Chk2 (05–649; 1:500 dilution; Millipore), rabbit anti-phospho-Chk2 (phospho-Thr68; 2661; 1:500 dilution; Cell Signaling Technology), rabbit anti-phospho-p53 (phospho-Ser15; 9284; 1:500 dilution; Cell Signaling Technology), rabbit anti-Akt (9272; 1:1000 dilution; Cell Signaling Technology), mouse anti-phospho-Akt (phospho-Ser473; 05–1003; 1:1000 dilution; Millipore), mouse anti-Rb (554136; 1:500 dilution; BD Bioscience), rabbit anti-phospho-PLK1 (phospho-Thr210; 5472 T; 1:1000 dilution; Cell Signaling Technology), rabbit anti-PLK1 (4513 T; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-CDC25A (phospho-Ser124; ab156574; 1:1000 dilution; abcam), rabbit anti-CDC25A (3652 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-CDC25B (phospho-Ser353; orb571847; 1:1000 dilution; Biorbyt), rabbit anti-CDC25B (9525; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-CDC25C (phospho-Ser216; 4901 T; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-CDC25C (phospho-Ser198; 9529 T; 1:1000 dilution; Cell Signaling Technology), rabbit anti-CDC25C (4688 T; 1:1000 dilution; Cell Signaling Technology), rabbit anti-cyclin A (sc-751; 1:200 dilution; Santa Cruz Biotechnology), mouse anti-cyclin B (sc-245; 1:250 dilution; Santa Cruz Biotechnology), mouse anti-cyclin D (sc-246; 1:200 dilution; Santa Cruz Biotechnology), mouse anti-cyclin E (sc-247; 1:250 dilution; Santa Cruz Biotechnology), rabbit anti-phospho-CDK1 (phospho-Thr161; 9114 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-phospho-CDK2 (phospho-Thr160; 2561 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-p21 (2947 S; 1:1000 dilution; Cell Signaling Technology), rabbit anti-p16 (ab108349; 1:1000 dilution; Abcam), rabbit anti-laminA (ab26300; 1:1000 dilution; Abcam), and mouse anti-GAPDH (G041; 1:1000 dilution; ABM). ..
Saline:Article Title: Hdac1-deficiency affects the cell cycle axis Cdc25-Cdk1 causing impaired G2/M phase progression and reduced cardiomyocyte proliferation in zebrafish.
Article Snippet: The membrane was blocked in SuperBlock (Thermo Fisher Scientific, Waltham, MA, USA) with 0.05% Tween for 30 min at RT and incubated with primary antibody in SuperBlock with 0.05% Tween at 4 C overnight. .. Primary antibodies used: rabbit anti-CDC25A (1:500 in 5% Tris-buffered saline with 0.05% Tween20 and 5% Bovine serum albumin, antibodies-online. com ABIN926907), rabbit anti-CDK1 (1:500, BioGenes anti-CAMK90761), rabbit anti-CDK2 (1:500, BioGenes anti-VYKA-90762), rabbit anti-Chk1 (1:500, Biorbyt orb574280), rabbit anti-Chk2 (1:1000, GeneTex GTX28108), rabbit anti-Histone H2A.XS139ph (1:1000, Genetex GTX127342), rabbit anti-p21 (1:500, Cell Signaling 2947), rabbit anti-p53 (1:1000, Biorbyt orb621461), and rabbit anti-pan Cadherin (1:1000, Abcam ab16505). .. Secondary antibodies anti-rabbit or anti-mouse IgG HRP-linked (Cell Signaling #7076/#7074) were incubated for 1 h at RT.
Bioprocessing:Article Title: Cajanine promotes osteogenic differentiation and proliferation of human bone marrow mesenchymal stem cells.
Article Snippet: Cajanine was obtained from Sigma-Aldrich (Shanghai, China). .. Rabbit anti-collagen I polyclonal antibody was purchased from Abcam (ab21286; Abcam, Cambridge, UK); rabbit anti-osteopontin polyclonal antibody was purchased from Abcam (ab8448); rabbit anti-Runx2 monoclonal antibody was purchased from Cell Signaling (No. 12556; Beverly, USA); phospho-Rb rabbit monoclonal antibody was purchased from Cell Signaling (No. 8516); rabbit antiCDK2 monoclonal antibody was purchased from Cell Signaling (No. 2546); rabbit anti-CDC25A and anti-CDC25B monoclonal antibodies were purchased from Cell Signaling (No. 3652, No. 9525); rabbit anti-cyclin B1 monoclonal antibody was purchased from Cell Signaling (No. 12231); and rabbit anti-α-tubulin monoclonal antibody was purchased from Cell Signaling (No. 2144). .. Osteogenic differentiation was performed by culturing 3 × 104 human BMSCs (hBMSCs) in a 6-well plate in Poietics® osteogenic induction medium (Lonza Walkersville, Inc., Walkersville, USA), which contained dexamethasone, ascorbic acid and β-glycerophosphate supplements.
|